{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T20:31:25Z","timestamp":1775334685450,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Startup Project of the Affiliated Huai\u2019an No.1 People\u2019s Hospital of Nanjing Medical University","award":["YGRS202005"],"award-info":[{"award-number":["YGRS202005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s13760-021-01601-9","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T18:02:50Z","timestamp":1611943370000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Botulinum toxin A improves psychological distress in patients with hemifacial spasm"],"prefix":"10.1007","volume":"122","author":[{"given":"Chengyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0070-1870","authenticated-orcid":false,"given":"Qiu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"11","key":"1601_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrneurol.2010.149","volume":"6","author":"EC Lim","year":"2010","unstructured":"Lim EC, Seet RC (2010) Use of botulinum toxin in the neurology clinic. Nat Rev Neurol 6(11):624\u2013636","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1601_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.WNL.0000042786.28267.B2","volume":"60","author":"EK Tan","year":"2003","unstructured":"Tan EK et al (2003) Is hypertension associated with hemifacial spasm? Neurology 60(2):343\u2013344","journal-title":"Neurology"},{"issue":"4","key":"1601_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ana.410320404","volume":"32","author":"CH Adler","year":"1992","unstructured":"Adler CH et al (1992) Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 32(4):502\u2013506","journal-title":"Ann Neurol"},{"issue":"9","key":"1601_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11136-011-9890-y","volume":"20","author":"S Setthawatcharawanich","year":"2011","unstructured":"Setthawatcharawanich S et al (2011) Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin. Qual Life Res 20(9):1519\u20131523","journal-title":"Qual Life Res"},{"issue":"5","key":"1601_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1227\/00006123-198505000-00005","volume":"16","author":"AR M\u00f8ller","year":"1985","unstructured":"M\u00f8ller AR, Jannetta PJ (1985) Microvascular decompression in hemifacial spasm: intraoperative electrophysiological observations. Neurosurgery 16(5):612\u2013618","journal-title":"Neurosurgery"},{"issue":"2","key":"1601_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3171\/jns.1995.82.2.0201","volume":"82","author":"FG Barker 2nd","year":"1995","unstructured":"Barker FG 2nd et al (1995) Microvascular decompression for hemifacial spasm. J Neurosurg 82(2):201\u2013210","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"1601_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01442.x","volume":"13","author":"K Frei","year":"2006","unstructured":"Frei K, Truong DD, Dressler D (2006) Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol 13(Suppl 1):30\u201335. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01442.x","journal-title":"Eur J Neurol"},{"issue":"19","key":"1601_CR8","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM et al (2008) Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70(19):1699\u20131706","journal-title":"Neurology"},{"issue":"1","key":"1601_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A et al (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18(1):5\u201318","journal-title":"Eur J Neurol"},{"issue":"1","key":"1601_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1473-2165.2009.00419.x","volume":"8","author":"MB Lewis","year":"2009","unstructured":"Lewis MB, Bowler PJ (2009) Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 8(1):24\u201326","journal-title":"J Cosmet Dermatol"},{"key":"1601_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi E, Rosenthal NE (2014) Treatment of depression with onabotulinumtoxin A: a randomized, double-blind, placebo controlled trial. J Psychiatr Res 52:1\u20136","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1601_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaad.2015.08.051","volume":"74","author":"JS Reichenberg","year":"2016","unstructured":"Reichenberg JS et al (2016) Botulinum toxin for depression: does patient appearance matter? J Am Acad Dermatol 74(1):171-173.e171","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1601_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0035-1559621","volume":"48","author":"M Magid","year":"2015","unstructured":"Magid M et al (2015) Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Pharmacopsychiatry 48(6):205\u2013210","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"1601_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/dsu.12175","volume":"39","author":"D Hexsel","year":"2013","unstructured":"Hexsel D et al (2013) Evaluation of self-esteem and depression symptoms in depressed and nondepressed subjects treated with onabotulinumtoxin A for glabellar lines. Dermatol Surg 39(7):1088\u20131096","journal-title":"Dermatol Surg"},{"issue":"5","key":"1601_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jpsychires.2012.01.027","volume":"46","author":"MA Wollmer","year":"2012","unstructured":"Wollmer MA et al (2012) Facing depression with botulinum toxin: a randomized controlled trial. J Psychiatr Res 46(5):574\u2013581","journal-title":"J Psychiatr Res"},{"key":"1601_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/NDT.S181820","volume":"15","author":"H Dong","year":"2019","unstructured":"Dong H et al (2019) Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. Neuropsychiatr Dis Treat 15:33\u201336","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"1601_CR17","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/mds.23906","volume":"26","author":"B Barahona-Corr\u00eaa","year":"2011","unstructured":"Barahona-Corr\u00eaa B et al (2011) Obsessive-compulsive symptoms in primary focal dystonia: a controlled study. Mov Disord 26(12):2274\u20132278","journal-title":"Mov Disord"},{"key":"1601_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1590\/S0004-282X2005000200004","volume":"63","author":"RP Munhoz","year":"2005","unstructured":"Munhoz RP et al (2005) Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm. Arq Neuropsiquiatr 63:213\u2013216","journal-title":"Arq Neuropsiquiatr"},{"key":"1601_CR19","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3389\/fpsyg.2016.01492","volume":"7","author":"P Perozzo","year":"2016","unstructured":"Perozzo P et al (2016) Sexual well-being in patients with blepharospasm, spasmodic torticollis, and hemifacial spasm: a pilot study. Front Psychol 7:1492","journal-title":"Front Psychol"},{"key":"1601_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2016.02.020","volume":"617","author":"S Ibragi\u0107","year":"2016","unstructured":"Ibragi\u0107 S et al (2016) Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats. Neurosci Lett 617:213\u2013217","journal-title":"Neurosci Lett"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-021-01601-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01601-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T14:28:42Z","timestamp":1646317722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-021-01601-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1007\/s13760-021-01601-9","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors in this study declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}